Phase IIIb Study to Evaluate Immunogenicity, Antibody Persistency and Reactogenicity of DTPa - INFANRIX and dTpa - BOOSTRIX Vaccines Administered to Healthy Children Previously Primed With 3 Doses of DTPa Vaccine Compared to Placebo (HAVRIX®JUNIOR)
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2016
At a glance
- Drugs DTaP vaccine; Hepatitis A vaccine inactivated
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline
- 12 Oct 2008 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 12 Oct 2008 Trial phase changed from III to IV as reported by ClinicalTrials.gov.
- 06 Nov 2007 New trial record.